Purinomia Biotech
Weston, US · Founded 2017 · Delaware corporation · 1 known investors
Purinomia is a clinical-stage biotechnology company developing therapeutics for cancer and inflammatory diseases. Its pipeline includes the clinical-stage program PUR001 and three pre-clinical programs (PUR002, PUR003, PUR004).
Founders & leadership
Purinomia Biotech was founded in 2017 by CEO & Scientific Founder.
C&
CEO & Scientific FounderCEO & Scientific Founder
SR
Simon RobsonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.3M disclosed across 8 rounds · 2017–2024
▶$1MraisedJun 2024 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedJun 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Qianye Karen LiuDirector
- Yan Wu ShangExecutive Officer, Director
- Shaoyong HuDirector
- Simon C. RobsonDirector
- Zhe WangExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1M
- Proceeds to insiders
- $200K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedNov 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedNov 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shaoyong HuDirector
- Yan Wu ShangExecutive Officer, Director
- Qianye Karen LiuDirector
- Zhe WangExecutive Officer, Director
- Simon C. RobsonDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Proceeds to insiders
- $100K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Qianye Karen LiuDirector
- Simon C. RobsonDirector
- Zhe WangExecutive Officer, Director
- Shaoyong HuDirector
- Yan Wu ShangExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJan 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJan 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zhe WangExecutive Officer, Director
- Qianye Karen LiuDirector
- Yan Wu ShangExecutive Officer, Director
- Simon C. RobsonDirector
- Shaoyong HuDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Proceeds to insiders
- $300K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedJan 2022 · 2 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJan 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Qianye Karen LiuDirector
- Yan Wu ShangExecutive Officer, Director
- Shaoyong HuDirector
- Simon C. RobsonDirector
- Zhe WangExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.3M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2MraisedFeb 2021 · 1 investors · BiotechnologyRule 506(b)
▶$2MraisedFeb 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yan Wu ShangExecutive Officer, Director
- Shaoyong HuDirector
- Zhe WangExecutive Officer, Director
- Qianye Karen LiuDirector
- Simon C. RobsonDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.8MraisedMay 2020 · 3 investors · BiotechnologyRule 506(b)
▶$2.8MraisedMay 2020 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yan Wu ShangExecutive Officer, Director
- Qianye Karen LiuDirector
- Simon C. RobsonDirector
- Shaoyong HuDirector
- Zhe WangExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $2.8M
- Proceeds to insiders
- $136K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$180KraisedNov 2017 · 1 investors · BiotechnologyRule 506(b)
▶$180KraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Simon RobsonExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $180K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Purinomia Biotech do?
- Purinomia is a clinical-stage biotechnology company developing therapeutics for cancer and inflammatory diseases. Its pipeline includes the clinical-stage program PUR001 and three pre-clinical programs (PUR002, PUR003, PUR004).
- Who founded Purinomia Biotech?
- Purinomia Biotech was founded by CEO & Scientific Founder in 2017.
- Who are Purinomia Biotech's investors?
- Purinomia Biotech's investors include BioVentures.
- How much funding has Purinomia Biotech raised?
- Purinomia Biotech has disclosed $10.3M raised across 8 rounds.
- Where is Purinomia Biotech headquartered?
- Purinomia Biotech is headquartered in Weston, US.